Devonian Health Group Inc. announced that it has refinanced the existing loan on its pharmaceutical facility. The loan from Investment Quebec (IQ) was terminated and replaced by one with a Private Group of Lenders (“PGL”). As of January 17, 2019, the residual on the IQ loan was $2,824,883. PGL has agreed to a loan of $3,000,000. In addition, PGL has amended the Loan terms as: Term of 5 years; PGL waives the monthly principal payments; PGL waives Devonian’s obligation to pay 5 % or 10% of equity raise through financing to offset the loan.